The international myeloma working group imwg has updated the diagnostic criteria for mm in 2014, adding 3 specific biomarkers that. The average risk of progression to multiple myeloma is around 1% per annum 3, 4. Plasma cells help you fight infections by making antibodies that recognize and attack germs. Criteria for a multiple myeloma diagnosis a physician can make a multiple myeloma diagnosis based on a physical exam, a patients symptoms, and findings from lab work, biopsies, and imaging studies. Multiple myeloma mm is a plasma cell pc malignancy of terminally differentiated b lymphocytes that is typically associated with the secretion of partial andor complete monoclonal immunoglobulins and a constellation of particular symptoms and signs. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Diagnostic criteria for plasma cell disorders plasma cell disorder definition smouldering multiple myeloma both criteria must be met. Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal. The median survival of the disease has doubled as a. Multiple myeloma can present with a wide constellation of symptoms including hypercalcaemia, anaemia, renal impairment andor bony pain. The current diagnostic criteria for symptomatic multiple myeloma are as follows. Imwg criteria for the diagnosis of myeloma and guidelines for. Fulltext pdf treatment outcomes in patients with newly diagnosed multiple myeloma who are ineligible for stemcell transplantation. Multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage.
A combination of these symptoms, particularly if unexpected or unexplained, should prompt diagnostic evaluation for myeloma. Pdf international myeloma working group guidelines for the. Multiple myeloma diagnosis and treatment mayo clinic. These current guidelines represent a major revision. Updated diagnostic criteria and staging system for multiple. International myeloma working group updated criteria for the. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. Last update for diagnostic criteria issued 2014 2014 imwg criteria for the diagnosis of mm clonal bone marrow plasma cells. Revised imwg diagnostic criteria for multiple myeloma and smouldering multiple myeloma. We hope that the information will be helpful to both healthcare professionals and patients. Multiple myeloma mm has been traditionally defined by the presence of endorgan damage, specifically, hypercalcemia, renal failure, anemia, and bone lesions crab features that are felt to be a consequence of the underlying clonal plasma cell proliferation. International uniform response criteria for multiple myeloma. Pdf international myeloma working group updated criteria for the. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma.
What are the imwg diagnostic criteria for multiple myeloma. A clarification to imwg criteria for coding cr and vgpr in patients in whom the only measurable. In the united states, the lifetime risk of getting multiple myeloma is 1 in 2 0. Role of 18ffdg petct in the diagnosis and management of multiple myeloma and other plasma cell disorders. Background multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage. International myeloma working group imwg criteria for the diagnosis of multiple myeloma. Consensus guidelines on the diagnosis of multiple myeloma and. Jul 11, 2016 the average risk of progression to multiple myeloma is around 1% per annum 3, 4. The international myeloma working group imwg has updated the criteria for diagnosing multiple myeloma and published the new criteria in the lancet oncology. The diagnosis of multiple myeloma requires the presence of one or more myeloma. Multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis. International myeloma working group diagnostic criteria and. Understanding clonal progression, evolution, and tides not only has helped elucidate the disease behavior but.
Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Revised international myeloma working group imwg criteria for the diagnosis of multiple myeloma both of the following criteria. Multiple myeloma accounts for 1% of all cancers and approximately 10% of all haematological malignancies. Monitor for multiple myeloma symptoms and m protein serum and urine every six to 12 months. The international myeloma working group imwg has updated the diagnostic criteria. New diagnostic criteria for multiple myeloma clinical lymphoma. Factors associated with poorer prognosis in multiple myeloma. Multiple myeloma affects slightly more men than women.
The revised international myeloma working group criteria for the diagnosis of mm and related disorders are shown in table 1. The guideline has been split into 2 documents, focussing on the diagnosis and management of multiple myeloma and supportive care in multiple myeloma 2011 snowden et al 2011. Table 1, below, outlines the revised imwg criteria for the diagnosis of myeloma. Plasma cells produce antibodies that help your body fight infections. For decades the diagnosis of multiple myeloma required the presence of endorgan damage. Consensus guidelines on the diagnosis of multiple myeloma. Diagnosis the revised international myeloma working group criteria for the diagnosis of multiple myeloma and related disorders are shown on table i 1. Key statistics about multiple myeloma multiple myeloma is a relatively uncommon cancer.
Jun 12, 2019 multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Multiple myeloma symptoms, diagnosis and treatment bmj. The median survival of the disease has doubled as a result of several new active. If the cancer has spread to a distant part of the body, the. New diagnostic criteria for multiple myeloma clinical. Multiple myeloma the path to diagnosis mymyelomateam. The diagnostic criteria for multiple myeloma and related disorders have been updated by the international myeloma working group. Multiple myeloma is the secondmost prevalent blood cancer 10% after nonhodgkins lymphoma. International myeloma working group imwg updated the diagnostic criteria for mm to add three specific biomarkers that can be used to diagnose.
Any one or more of the following myeloma defining events. Consensus recommendations for standard investigative workup. New imwg diagnostic criteria allows earlier diagnosis ash. New criteria for diagnosing multiple myeloma mayo clinic. New diagnostic criteria for myeloma nssg haematology. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma. Aug 16, 2018 the revised international myeloma working group criteria for the diagnosis of multiple myeloma and related disorders are shown on table 1. Updated diagnostic criteria and staging system for. Serum monoclonal protein igg or iga 3 gdl, or urinary monoclonal protein 500 mg per 24 h andor clonal bone marrow plasma cells 10%60% absence of myeloma defining events or amyloidosis multiple myeloma both criteria must be met. Multiple myeloma is a plasma cell malignancy, with one of the longest diagnostic pathways of all cancers in the uk. These updated esmo clinical practice guidelines cover the diagnosis and pathologymolecular biology, staging and risk assessment and response evaluation of multiple myeloma. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow.
The international staging system is the current standard for staging of myeloma. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are recommended by the working group for the diagnosis of myeloma and related organ dysfunction. New systems have emerged for diagnosis, staging and response assessment in multiple myeloma mm. Multiple myeloma is the second most common type of blood cancer after leukemia. In 2006 guidelines for the diagnosis and management of multiple myeloma were published smith et al, 2006. Patients with 60% or more clonal plasma cell involvement. Serum monoclonal protein nonigm type, 3 gdl clonal bone marrow plasma cells, 10%.
Evidence of end organ damage that can be attributed to the underlying plasma cell proliferative disorder, specifically. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Dec 05, 2015 in 2014, the international myeloma working group imwg revised the diagnostic criteria for mm. Evaluation history and physical blood workup cbc with differential and platelet counts bun, creatinine. Serum m protein igg or iga 30gl or urinary m protein 500mg per 24h andor clonal bm plasma cells 10%60% absence of myelomade. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma and related disorders. Objective multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis.
Group revised the diagnostic criteria for multiple myeloma. Allogeneic hsct for multiple myeloma icd 10cm codes c90. High risk factors the following tests for highrisk disease are routinely available in australia and are recommended. There has been remarkable progress made in the diagnosis and treatment of multiple myeloma mm. Work up of plasma cell disorders involves establishing the presence of a monoclonal. Updated criteria for the diagnosis of multiple myeloma managing. The above mm diagnostic criteria was created by durie and salmon in 1975, after a study in which the presenting clinical features of 71 patients with multiple myeloma were correlated with myeloma cell mass myeloma cells x 10 12 m 2 of body surface area. Objective multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis and provides an overview of management. Myeloma guidelines v4 2018 health and care together syb. Multiple myeloma early detection, diagnosis, and staging 1. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. International myeloma working group imwg updated criteria for the diagnosis of multiple myeloma1 and. Treatment recommendations address frontline treatment of both. Smoldering multiple myeloma both criteria must be met.
Our group, which includes more than 180 myeloma researchers worldwide, has updated the definition of multiple myeloma for diagnostic. Criteria for diagnosis, staging, risk stratification and. These new criteria add myeloma defining events, the presence of any one of which is sufficient to diagnose multiple myeloma. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. New diagnostic criteria 29 options for patients who are not candidates for stem cell transplant 33 transplantation 36 radiation 41. Clonal bone marrow plasma cells 10% or biopsyproven bony or. Updated diagnostic criteria and staging system for multiple myeloma. For the 5% of people who are diagnosed at an early stage, the 5year survival rate is 71%. Patients with 60% or more clonal plasma cell involvement of the marrow, serum free light chain ratio of 100 or higher provided involved free light chain level. Imwg criteria for the diagnosis of mm inl myeloma fn.
Recent advances in understanding multiple myeloma version. Rajkumar sv, dimopoulos ma, palumbo a, blade j, merlini g, et al. Apr 25, 2018 to adapt to such an overall favorable therapeutic environment, in addition to better understanding of the biology of the disease, 36 in 2014, the updated imwg diagnostic criteria 1 were established with the addition of three diagnostic biomarkers to the previously described signs of a multiple myeloma diagnosis ie, crab featureselevated calcium level, renal failure, anemia, and bone lesions. International myeloma working group updated criteria for. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. The american cancer society s estimates for multiple myeloma. Multiple myeloma is diagnosed based on the results of clinical tests. Updated international myeloma working group criteria. Another transitional phase on the way to symptomatic multiple myeloma is smoldering asymptomatic myeloma, which, in common with monoclonal gammopathy of uncertain significance, is characterized by the absence of organ damage crab criteria table 1. Jan 31, 2017 multiple myeloma is a type of cancer caused by malignant plasma cells in your bone marrow. Multiple myeloma early detection, diagnosis, and staging. Myeloma is a cancer of the plasma cells in the bone marrow.
Multiple myeloma mm accounts for 1% of all cancers and. Imwg criteria for the diagnosis of myeloma and guidelines for the. International myeloma working group diagnostic criteria for multiple myeloma and related plasma cell disorders disorder disease definition nonigm mgus all three criteria must be met. Theses recommendations are excerpted from palumbo a et.
Revised imwg diagnostic criteria for multiple myeloma. Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal immunoglobulin or immunoglobulin fragment in the serum andor urine. Diagnostic criteria have been revised and former ultrahighrisk smoldering multiple myeloma is now considered multiple myeloma in need of treatment. The diagnostic and response criteria recommended are primarily derived from the international myeloma working group, with certain updates and clarifications.
1488 1457 599 1497 1375 756 1586 1351 432 1614 49 816 1366 238 471 1404 1346 800 312 732 393 1265 1285 748 1393 1220 1386 1029 765 927 893 269 753 433